Funded Tech Companies
Endeavor BioMedicines
Wondering who invested in Endeavor BioMedicines? Omega Funds, Longitude Capital Management and private investors joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Endeavor BioMedicines
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
514 Via de la Valle 203
Solana Beach, CA 92075
USA
Solana Beach, CA 92075
USA
Phone
Website
Email Address
Company Background Information
Overview
Endeavor BioMedicines is developing new treatments targeting the underlying causes of pulmonary fibrosis. The company is developing taladegib, a small-molecule inhibitor of the Hedgehog signaling pathway, that is being investigated for the treatment of idiopathic pulmonary fibrosis (IPF).
Last Transaction
1/8/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Company Investors
- Omega Funds (Bernard Davitian)
- Longitude Capital Management (Sandip Agarwala)
Browse more funded tech companies:
Endear Health | Endeca Technologies
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs